Bookbuilding IPO | ₹45 Cr | Listed at NSE SME | Thu, Jul 4, 2024 - Mon, Jul 8, 2024
Ambey Laboratories IPO is a book build issue of ₹44.68 crores. The issue is a combination of fresh issue of 0.63 crore shares aggregating to ₹42.55 crores and offer for sale of 0.03 crore shares aggregating to ₹2.12 crores.
Ambey Laboratories IPO bidding started from Jul 4, 2024 and ended on Jul 8, 2024. The allotment for Ambey Laboratories IPO was finalized on Jul 9, 2024. The shares got listed on NSE SME on Jul 11, 2024.
Ambey Laboratories IPO price band is set at ₹68 per share. The lot size for an application is 2,000. The minimum amount of investment required by an retail is ₹1,36,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,72,000.
Fast Track Finsec Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Nikunj Stock Brokers Ltd..
Refer to Ambey Laboratories IPO RHP for detailed Information.
IPO Open
Thu, Jul 4, 2024
IPO Close
Mon, Jul 8, 2024
Issue Price
₹68 per share
Market Cap (Pre-IPO)
₹171.64 Cr
| IPO Date | 4 to 8 Jul, 2024 |
| Listed on | Thu, Jul 11, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹65 to ₹68 |
| Issue Price | ₹68 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 65,70,000 shares (agg. up to ₹45 Cr) |
| Reserved for Market Maker | 3,30,000 shares Nikunj Stock Brokers Ltd. (agg. up to ₹2 Cr) |
| Fresh Issue (Ex Market Maker) | 59,28,000 shares (agg. up to ₹40 Cr) |
| Offer for Sale | 3,12,000 shares of ₹10 (agg. up to ₹2 Cr) |
| Net Offered to Public | 62,40,000 shares (agg. up to ₹42 Cr) |
| Share Holding Pre Issue | 1,86,88,819 shares |
| Share Holding Post Issue | 2,52,58,819 shares |
| NSE Symbol | AMBEY |
| ISIN | INE0M3I01029 |
Ambey Laboratories IPO comprises a total issue size of 65,70,000 shares. The net offer to the public is 62,40,000 shares, after excluding 3,30,000 shares allotted on a firm basis. Of the Net offer 31,20,000 (50.00%) are allocated to QIB, 9,36,000 (15.00%) allocated to NII 21,84,000 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 31,20,000 | 50.00% | 47.49% |
| − Anchor Investor Shares Offered | 18,72,000 | 28.49% | |
| − QIB (Ex. Anchor) Shares Offered | 12,48,000 | 19.00% | |
| NII (HNI) Shares Offered | 9,36,000 | 15.00% | 14.25% |
| Retail Shares Offered | 21,84,000 | 35.00% | 33.24% |
| Firm Reservations | |||
| Market Maker Shares Offered | 3,30,000 | 5.02% | |
| Total Shares Offered | 65,70,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,36,000 |
| Retail (Max) | 1 | 2,000 | ₹1,36,000 |
| HNI (Min) | 2 | 4,000 | ₹2,72,000 |
Ambey Laboratories IPO raises ₹12.73 crore from anchor investors. Ambey Laboratories IPO Anchor bid date is July 3, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Wed, Jul 3, 2024 |
| Shares Offered | 18,72,000 |
| Anchor Portion (₹ Cr.) | 12.73 |
| Anchor lock-in period end date for 50% shares (30 Days) | Thu, Aug 8, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | Mon, Oct 7, 2024 |
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
The company manufactures and supplies 2,4-D base chemicals.
The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.
The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:
As of October 31, 2023 the company employs 220 people in various departments.
| Period Ended | 31 Jan 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 86.21 | 57.62 | 55.93 | 44.62 |
| Total Income | 100.44 | 107.43 | 85.11 | 82.42 |
| Profit After Tax | 6.08 | 4.57 | 3.57 | 10.34 |
| NET Worth | 34.31 | 23.64 | 19.07 | -7.86 |
| Reserves and Surplus | 15.62 | 5.89 | 1.32 | -12.76 |
| Total Borrowing | 20.05 | 13.65 | 18.05 | 32.93 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet out the Working Capital requirements | 30.93 |
| 2 | To meet out the General Corporate Purposes | 9.12 |
| 3 | Issue Expenses | 2.50 |
| KPI | Jan 31, 2024 |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt/Equity | 0.58 |
| RoNW | 20.80% |
| PAT Margin | 6.01% |
| Price to Book Value | 3.58 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 2.44 | 2.89 |
| P/E (x) | 27.81 | 23.54 |
| Promoter Holding | 94.97% | 69.9% |
| Market Cap | ₹171.64 Cr. |
The Ambey Laboratories IPO is subscribed 173.18 times on July 8, 2024 6:19:58 PM (Day 3). The public issue subscribed 195.06 times in the retail category, 61.9 times in the QIB category, and 324.22 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 61.9 | 12,52,000 | 7,74,96,000 |
| NII* | 324.22 | 6,06,001 | 19,64,76,000 |
| Retail | 195.06 | 21,84,000 | 42,60,14,000 |
| Total | 173.18 | 40,42,001 | 69,99,86,000 |
Total Application : 2,13,007
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manger Fees | 0.20 |
| 2 | Fees Payable to Registrar to the Issue | 0.02 |
| 3 | Fees Payable for Advertising and Publishing Expense | 0.02 |
| 4 | Fees Payable to Regulators including Stock Exchanges | 0.05 |
| 5 | Payment for Printing & Stationery, Postage, etc. | 0.02 |
| 6 | Fees Payable to Auditor, Legal Advisors and other Professionals | 0.09 |
| 7 | Others (Fees payable for Marketing & distribution expenses, Selling Commission, Brokerage, Processing Fees*, Underwriting fees and Miscellaneous Expenses) | 2.10 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹68.00 |
| Open | ₹85.00 |
| Low | ₹85.00 |
| High | ₹89.25 |
| Last Trade | ₹89.25 |
Lead Manager Reports
Ambey Laboratories IPO is a SME IPO of 65,70,000 equity shares of the face value of ₹10 aggregating up to ₹45 Crores. The issue is priced at ₹68 per share. The minimum order quantity is 2000.
The IPO opens on Thu, Jul 4, 2024, and closes on Mon, Jul 8, 2024.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Ambey Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Ambey Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Ambey Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Ambey Laboratories IPO opens on Thu, Jul 4, 2024 and closes on Mon, Jul 8, 2024.
Ambey Laboratories IPO lot size is 2000, and the minimum amount required for application is ₹1,36,000.
You can apply in Ambey Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Ambey Laboratories IPO will be done on Tuesday, July 9, 2024, and the allotted shares will be credited to your demat account by Wed, Jul 10, 2024. Check the Ambey Laboratories IPO allotment status.
The Ambey Laboratories IPO listing date is on Thu, Jul 11, 2024.
